"Dry Powder Inhaler Manufacturing: Case Studies on How Powder Properties Influence Processing and Performance"
Lecture and Networking Reception
Thursday, May 16th, 2024 5-6pm: Networking Reception 6-7pm: Presentations 7-7:30pm: Additional networking Genentech, 601 Gateway Blvd. 1st Floor, South San Francisco
Speaker Bios Julie D. Suman, R.Ph., Ph.D.
Dr. Julie D. Suman is the Vice President of Scientific Affairs for Aptar Pharma. She manages strategic scientific planning and Aptar’s Scientific Advisory Board. Dr. Suman is also the co-founder of Next Breath. She holds a B.S. in Pharmacy from Duquesne University (1996) and a Ph.D. in Pharmaceutical Sciences from the University of Maryland, Baltimore (2002). Dr. Suman serves on the External Advisory Committee of the New South Wales RNA Production and Research Network. In addition, she is a co-editor for Respiratory Drug Delivery Proceedings, an international symposium, and an Affiliate Assistant Professor in the Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University. Dr. Suman is the Past-Chair of the AAPS Inhalation Technology Focus Group. Dr. Suman is also a member of the Parental Drug Association Visible Particulate Taskforce. She is a licensed Maryland pharmacist. Dr. Suman has published her research in peer-reviewed journals and has been presented during podium sessions at international meetings, the FDA Topics in Bioequivalence Seminar Series and has been an invited speaker at ANVISA in Brazil. Dr. Suman’s doctoral research, which focused on the relationship between in vitro tests for nasal sprays and in vivo deposition, has been recognized for excellence by a research award presented at the International Society for Aerosols in Medicine, 2001. In 2008, Dr. Suman received an award from the Greater Baltimore Committee for Entrepreneurial Spirit.
Irene Rossi, Ph.D.
Dr. Irene Rossi is currently working at Harro Höfliger (DE) as Consultant Inhalation Technology supporting the team and clients on topics related to novel and established drug delivery technologies, particularly focused on nasal and inhalation delivery. Irene obtained a MSc in 2014 and a PhD in Drugs, Biomolecules and Health Products at the University of Parma (Italy) in 2019. During her PhD she spent 6 months at College of Pharmacy, University of New Mexico (Albuquerque, NM, USA), where she acquired competences also on in vitro cell and bacteria cultures and in vivo preclinical studies. She was selected as finalist for the Drug Delivery to the Lungs Pat Burnell New Investigator Award in 2017 with a work on pulmonary vaccination against Human Papillomavirus and, again, in 2018 with a work on the development of spray dried polymeric nano-embedded microparticles for tuberculosis and not tuberculous mycobacterial infections.In 2019 she joined Nanopharm, An Aptar Pharma Company (UK) where she covered different roles. Most recently, she was leading a group focused on the development and characterization of new formulation technologies for OINDP products comprising both small and large molecules as Head of New Modalities.Up to date, Irene has published 7 original papers and 3 patent applications on the development of a dry powder for pulmonary vaccination and re-formulation of pressurised metered dose inhaler with low global warming potential propellants. She presented her work at more than 20 international conferences.
$10 - regular fee $5 - student, unemployed, or retired
Sponsors
AAPS-BADG
Our mission is to connect anyone who is interested in the advancement of pharmaceutical science, so they can learn from scientists who are willing to share operational, scientific and educational expertise.
